Compared with normal tissues, SLC2A4 was significantly downregulated in patients with all subtypes and stages of BRCA, and high level of SCL2A4 in luminal A breast cancer and stage III breast cancer can significantly predict better prognosis. Here, SLC2A4 is linked to breast cancer.